Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CWBC
4201
Community West Bancshares
CWBC
$701M
| $1.49M | ﹤0.01% |
69,203
-31,594
| -31% | -$681K |
|
|
GAN
4202
CALL
DELISTED
GAN Ltd
GAN
| $1.49M | ﹤0.01% |
+100,000
| New | +$1.6M |
|
4203
Nature's Sunshine
NATR
$250M
| $1.49M | ﹤0.01% |
101,487
+17,935
| +21% | +$301K |
|
4204
Amkor Technology
AMKR
$11.9B
| $1.49M | ﹤0.01% |
59,539
-30,702
| -34% | -$783K |
|
|
SOFIW
4205
CALL
DELISTED
SoFi Technologies, Inc. Warrants
SOFIW
| $1.49M | ﹤0.01% |
238,750
-169,627
| -42% | -$1.03M |
|
|
TTOO
4206
DELISTED
T2 Biosystems, Inc
TTOO
| $1.48M | ﹤0.01% |
324
-409
| -56% | -$2.06M |
|
|
CCAIU
4207
DELISTED
Cascadia Acquisition Corp. Unit
CCAIU
| $1.48M | ﹤0.01% |
+150,000
| New | +$1.48M |
|
4208
Cabaletta Bio
CABA
$529M
| $1.48M | ﹤0.01% |
121,624
-868,706
| -88% | -$8.01M |
|
4209
PUT
Regions Financial
RF
$25.8B
| $1.48M | ﹤0.01% |
69,400
-32,200
| -32% | -$641K |
|
4210
CALL
Clover Health Investments
CLOV
$2.25B
| $1.48M | ﹤0.01% |
+200,000
| New | +$1.71M |
|
|
PWOD
4211
DELISTED
Penns Woods Bancorp
PWOD
| $1.48M | ﹤0.01% |
62,083
-39,747
| -39% | -$942K |
|
4212
Teradata
TDC
$2.68B
| $1.47M | ﹤0.01% |
25,701
-30,659
| -54% | -$1.58M |
|
4213
EVgo
EVGO
$196M
| $1.47M | ﹤0.01% |
180,526
+129,575
| +254% | +$1.31M |
|
4214
Marcus & Millichap
MMI
$1.23B
| $1.47M | ﹤0.01% |
36,110
-51,072
| -59% | -$1.98M |
|
|
JBIO
4215
Jade Biosciences
JBIO
$1.33B
| $1.47M | ﹤0.01% |
1,996
+138
| +7% | +$77.3K |
|
4216
Douglas Emmett
DEI
$1.97B
| $1.47M | ﹤0.01% |
46,386
-307,438
| -87% | -$10.1M |
|
4217
Everest Group
EG
$14.5B
| $1.47M | ﹤0.01% |
5,840
-45,318
| -89% | -$11.6M |
|
4218
Central Pacific Financial
CPF
$974M
| $1.46M | ﹤0.01% |
56,995
-31,860
| -36% | -$798K |
|
|
TYME
4219
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $1.46M | ﹤0.01% |
1,420,190
-702,388
| -33% | -$773K |
|
4220
Rollins
ROL
$17.5B
| $1.46M | ﹤0.01% |
41,371
-67,982
| -62% | -$2.54M |
|
4221
Microvision
MVIS
$56.3M
| $1.46M | ﹤0.01% |
8,802
+1,551
| +21% | +$323K |
|
|
FACT.U
4222
DELISTED
Freedom Acquisition I Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
FACT.U
| $1.46M | ﹤0.01% |
147,435
-495,014
| -77% | -$4.92M |
|
4223
1st Source
SRCE
$2.08B
| $1.46M | ﹤0.01% |
30,860
+12,747
| +70% | +$580K |
|
4224
Norwood Financial Corp
NWFL
$372M
| $1.46M | ﹤0.01% |
56,667
-32,668
| -37% | -$830K |
|
|
HCICW
4225
CALL
DELISTED
Hennessy Capital Investment Corp. V Warrant
HCICW
| $1.46M | ﹤0.01% |
1,165,380
+248,115
| +27% | +$381K |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.